| Literature DB >> 28263602 |
Yuan Xu1,2, Liang Li1, Yulan Wang1,2, Jing Xing1,2, Lei Zhou1,2, Dafang Zhong1, Xiaomin Luo1, Hualiang Jiang1, Kaixian Chen1, Mingyue Zheng1, Pan Deng1, Xiaoyan Chen1.
Abstract
Aldehyde oxidase (AOX) is an important drug-metabolizing enzyme. However, the current in vitro models for evaluating AOX metabolism are sometimes misleading, and preclinical animal models generally fail to predict human AOX-mediated metabolism. In this study, we report a combined computational and experimental investigation of drug-like molecules that are potential aldehyde oxidase substrates, of which multiple sites of metabolism (SOMs) mediated by AOX and their preferences for the reaction can be unambiguously identified. In addition, the proposed strategy was used to evaluate the metabolism of newly designed c-Met inhibitors, and a success switch-off of AOX metabolism was observed. Overall, this study provide useful information to guide lead optimization and drug discovery based on AOX-mediated metabolism.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28263602 DOI: 10.1021/acs.jmedchem.7b00019
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446